Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a 30-Plant drink ease PTSD? new trial tests Gut-Brain link

NCT ID NCT07107269

Ongoing Disease control Sponsor: Colorado State University Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial investigates whether drinking a beverage made from 30 different organic vegetables daily for four weeks can improve gut microbiome diversity, reduce inflammation, and ease PTSD symptoms in adults diagnosed with PTSD. Participants are randomly assigned to receive either the high-diversity drink or a low-diversity drink made from three vegetables. The study measures changes in PTSD severity, gut bacteria, and markers of inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a high-diversity plant beverage made from 30 organic vegetables
What this could lead to
If it works, this could point toward a simple dietary approach to help manage PTSD symptoms by improving gut health.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply broadly. The effect on PTSD symptoms may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PTSD - POST TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

combat disorder post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PTSD - POST TRAUMATIC STRESS DISORDER

Contacts and locations

Locations

  • Food and Nutrition Clinical Research Lab - Colorado State University

    Fort Collins, Colorado, 80523, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.